Phase I/II BRUIN study: pirtobrutinib in patients intolerant to a covalent BTK inhibitor
9 months ago
[{"url":"https://i.ytimg.com/vi/kS9TP5cojzw/hq720.jpg?sqp=-oaymwEcCOgCEMoBSFXyq4qpAw4IARUAAIhCGAFwAcABBg==&rs=AOn4CLB1dOyIHL-YSCldSCkh2ScLzt7aHQ","width":360,"height":202},{"url":"https://i.ytimg.com/vi/kS9TP5cojzw/hq720.jpg?sqp=-oaymwEcCNAFEJQDSFXyq4qpAw4IARUAAIhCGAFwAcABBg==&rs=AOn4CLAERsK0A2JfA2fWZ0zwmAbO4oftyw","width":720,"height":404}]
{"url":"https://i.ytimg.com/an_webp/kS9TP5cojzw/mqdefault_6s.webp?du=3000&sqp=CMCdsKkG&rs=AOn4CLDceXxK04bFthlxUZLgd2LzYyX3XQ","width":320,"height":180}
[{"text":"In this "},{"text":"video","bold":true},{"text":" Nirav Shah, MD, Medical College of Wisconsin, Milwaukee, WI, comments on results from a subset of patients in the\u00a0..."}]
{"name":"VJHemOnc \u2013 Video Journal of Hematological Oncology","id":"UCsQXL4_zTA-FoG9RA1tEGiw","thumbnails":[{"url":"https://yt3.ggpht.com/tLfkaYbACnFuAto-jU_XMyorvysy280aW3Kj1oDAKOH7nd58XYlz5rEL24x9ScNjruMr2YYw9w=s68-c-k-c0x00ffffff-no-rj","width":68,"height":68}],"link":"https://www.youtube.com/channel/UCsQXL4_zTA-FoG9RA1tEGiw"}
{"title":"Phase I/II BRUIN study: pirtobrutinib in patients intolerant to a covalent BTK inhibitor by VJHemOnc \u2013 Video Journal of Hematological Oncology 79 views 9 months ago 1 minute, 8 seconds","duration":"1 minute, 8 seconds"}